Biomedical Translation Bridge initiative
The Biomedical Translation Bridge (BTB) is now part of the Medical Research Commercialisation initiative under the MRFF 10-year plan.
What is the Biomedical Translation Bridge?
The Biomedical Translation Bridge (BTB) funds and nurtures early-stage health and medical research to reach proof-of-concept with the potential to attract further capital and support. It is now part of the Medical Research Commercialisation initiative under the MRFF 10-year plan.
Why is the Biomedical Translation Bridge important?
The BTB helps researchers transform their ideas into new treatments to help tomorrow’s patients.
Early-stage research is the first step towards future medical treatments. Taking a project from an idea to a final product is a long and expensive process. The BTB helps Australian medical researchers develop life-saving medicines, devices and treatments.
The BTB helps boost overall investment in biomedical research. This is because projects also attracted matched funding from other sources.
What are the goals of the Biomedical Translation Bridge?
The BTB addresses key national gaps in Australia’s research sector and support three goals:
- increased commercialisation focus and expertise in early stage research and decision-making across Australia
- accelerated development, and improved success
- helped to identify existing and new sources of capital investment to bolster awareness and interest in early research investment opportunities
How will we meet these goals?
After a competitive process, the Government chose MTPConnect to deliver the BTB. MTPConnect is a not-for-profit organisation formed to accelerate the growth of Australia’s medical technologies, biotechnologies and pharmaceuticals sector.
Who works with us on the Biomedical Translation Bridge?
The BTB is part of the Australian Government’s Medical Research Future Fund (MRFF).
MTPConnect has partnered with the following organisations to deliver the BTB:
- BioCurate, founded by the University of Melbourne and Monash University to boost development of new medicines
- UniQuest, the University of Queensland’s specialist centre for commercialising intellectual property
- Medical Device Partnering Program (MDPP), led by Flinders University to turn ideas for medical devices into realities
Apply for funding
See MTPConnect’s Biomedical Translation Bridge page for information about funding opportunities.
The Biomedical Translation Bridge now forms part of the Medical Research Commercialisation initiative.
For more information contact MTPConnect.
MTPConnect is administering the REDI, the Biomedical Translation Bridge and the BioMedTech Horizons initiatives. Contact MTPConnect during business hours for information about these initiatives (funded by the Medical Research Future Fund).